Brief: Caplin Point Laboratories Says Commencement Of Operations By Caplin One Labs
March 27 (Reuters) - Caplin Point Laboratories Ltd
CAPL.NS :
* COMMENCEMENT OF OPERATIONS BY CAPLIN ONE LABS
* CAPLIN GROUP COMPLETES NEW ONCOLOGY (ANTI-CANCER) FACILITY
* UNIT WILL FOCUS ON MANUFACTURING RANGE OF ORAL SOLID
DOSAGE
ONCOLOGY PRODUCTS
* PLANS TO EXPAND PORTFOLIO TO OVER 50 ONCOLOGY PRODUCTS
PROGRESSIVELY
* ONCOLOGY PRODUCTS WILL BE TARGETED AT LATIN AMERICAN
COUNTRIES
INITIALLY
* IN MEDIUM TERM, TO LAUNCH PRODUCTS IN REGULATED MARKETS
SUCH AS
US, EU, MEXICO, OTHERS
* INJECTABLE DIVISION TO COMMENCE OPERATIONS IN NEXT FEW
MONTHS
Source text for Eikon: ID:nBSE4N2lKR
Further company coverage: CAPL.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees